The Wiley Knowledge Hubs publish and curate a range of relevant and quality-controlled digital assets on research topics in the health and life sciences designed for the realities of today’s medical practice. Our hubs are separated via subject area for easy navigation, providing quick access to the latest research and resources that can be applied to your everyday work and education.Â
The Wiley Multiple Myeloma Knowledge Hub provides the latest clinically relevant content from trusted sources on the evolving treatment landscape and management of adverse events, such as cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS), for patients with relapsed refractory multiple myeloma. Â
Aimed at community oncologists, hematology-oncologists, nurses, nurse practitioners, and pharmacists, this resource offers access to real-world case studies and practical experiences that reflect real-life scenarios. Â
The goal of the Knowledge Hub is to educate these healthcare professionals about novel therapies and current research, equipping them with the tools to effectively apply best-practice recommendations to enhance patient care. Â
All content published on the resource is reviewed by our independent expert editorial panel and presented in an accessible format for easy application in everyday clinical practice.Â
The resource has been supported by Janssen Pharmaceuticals. Aside from a medical accuracy review, the supporter has had no influence in the selection and creation of content.Â